These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11861259)

  • 1. "Special delivery" to cancer cells.
    Fefer A
    Blood; 2002 Mar; 99(5):1503-4. PubMed ID: 11861259
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix.
    Carnemolla B; Borsi L; Balza E; Castellani P; Meazza R; Berndt A; Ferrini S; Kosmehl H; Neri D; Zardi L
    Blood; 2002 Mar; 99(5):1659-65. PubMed ID: 11861281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted monoclonal antibody-based treatment of hematological malignancies.
    Kaspers GJ
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):253-5. PubMed ID: 12820769
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells.
    Schanzer JM; Fichtner I; Baeuerle PA; Kufer P
    J Immunother; 2006; 29(5):477-88. PubMed ID: 16971804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of human recombinant antibodies to the marker of angiogenesis ed-b in cancer therapy.
    Borsi L; Carnemolla B; Neri D; Zardi L
    Tumori; 2001; 87(6):S8-10. PubMed ID: 11989617
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving the efficacy of antibody-based cancer therapies.
    Carter P
    Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of phage display for the development of tumour targeting agents.
    Nilsson F; Tarli L; Viti F; Neri D
    Adv Drug Deliv Rev; 2000 Sep; 43(2-3):165-96. PubMed ID: 10967225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of T cell-mediated immune responses by antibody-cytokine fusion proteins.
    Lode HN; Xiang R; Gillies SD; Reisfeld RA
    Immunol Invest; 2000 May; 29(2):117-20. PubMed ID: 10854178
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeted delivery of tissue factor to tumor neovasculature for cancer therapy.
    Neri D
    Haemostasis; 2001; 31 Suppl 1():21-2. PubMed ID: 11990467
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer: one step at a time.
    Mooney D
    Nature; 2005 Jul; 436(7050):468-9. PubMed ID: 16049458
    [No Abstract]   [Full Text] [Related]  

  • 11. The targeted delivery of IL17 to the mouse tumor neo-vasculature enhances angiogenesis but does not reduce tumor growth rate.
    Pasche N; Frey K; Neri D
    Angiogenesis; 2012 Mar; 15(1):165-9. PubMed ID: 22052195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo behaviour of antibody-drug conjugates for the targeted treatment of cancer.
    Xie H; Blättler WA
    Expert Opin Biol Ther; 2006 Mar; 6(3):281-91. PubMed ID: 16503736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keys to unlock cancer: targeted therapy.
    Viele CS
    Oncol Nurs Forum; 2005 Sep; 32(5):935-40. PubMed ID: 16136192
    [No Abstract]   [Full Text] [Related]  

  • 14. Regression of CD30+ cutaneous anaplastic large-cell lymphoma with denileukin diftitox.
    Dao H; Barr PM; Honda K
    J Am Acad Dermatol; 2011 Jun; 64(6):e123-5. PubMed ID: 21571160
    [No Abstract]   [Full Text] [Related]  

  • 15. Toward a systems engineering approach to cancer drug delivery.
    Dreher MR; Chilkoti A
    J Natl Cancer Inst; 2007 Jul; 99(13):983-5. PubMed ID: 17596569
    [No Abstract]   [Full Text] [Related]  

  • 16. A human cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM overexpressing tumor cells.
    Schanzer JM; Baeuerle PA; Dreier T; Kufer P
    Cancer Immun; 2006 Feb; 6():4. PubMed ID: 16483188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reengineering the Tumor Vasculature: Improving Drug Delivery and Efficacy.
    Stylianopoulos T; Munn LL; Jain RK
    Trends Cancer; 2018 Apr; 4(4):258-259. PubMed ID: 29606306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer.
    Seo BR; DelNero P; Fischbach C
    Adv Drug Deliv Rev; 2014 Apr; 69-70():205-216. PubMed ID: 24309015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The critical role of vascular endothelial growth factor in tumor angiogenesis.
    Amini A; Masoumi Moghaddam S; Morris DL; Pourgholami MH
    Curr Cancer Drug Targets; 2012 Jan; 12(1):23-43. PubMed ID: 22111836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of tumor endothelial cells and drug delivery.
    Hida K; Maishi N; Sakurai Y; Hida Y; Harashima H
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):140-147. PubMed ID: 26626622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.